Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity
NCT01954563
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
BIOLOGICAL:
MVA85A
Sponsor
University of Oxford